Viewing Gene With Clinical Trials Data


Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/

Symbol: VKORC1
Name: vitamin K epoxide reductase complex subunit 1
Location: 16p11.2
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product

Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT00334464 A Pharmacogenetic Study of Warfarin Dosing The COUMA-GEN Study View
NCT01119274 EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon View
NCT01119261 EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol View
NCT01318057 Pharmacogenetics of Warfarin in Puerto Ricans View
NCT00970892 VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management View
NCT02191358 YouScript IMPACT Registry View
NCT01006733 Genetics Informatics Trial GIFT of Warfarin to Prevent DVT View
NCT00927862 Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin View
NCT03285100 The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation View
NCT01119300 EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin View
NCT00634907 Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin Coumadin View
NCT01610141 Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients View
NCT01633957 A Trial of Genotype-based Warfarin Initiation in Patients With Mechanical Prosthetic Heart Valve View
NCT00904293 Genotype-Guided Warfarin Therapy Trial View
NCT03015025 Pharmacogenetic Dosage Algorithm for Acenocoumarol View
NCT04001166 Pharmacogenomics of Antithrombotic Drugs -a Register Linkage Study With National Registries and Biobanks in Finland View
NCT05609500 Warfarin Dosage Adjustment Model Analysis Study View
NCT02525887 Identify Genetic Variations That Affect The Ability of Patients To Metabolize Drugs Through Metabolic Pathways View
NCT03797534 Individualized Administration of Warfarin by Polymorphisms of VKORC1 and CYP2C9 Genes View
NCT00990158 Does Low Dose Oral Vitamin K Improve International Normalized Ratio INR Stability View
NCT01050920 Study of Genetic Factors Other Than CYP2C9 and VKORC1 That Influence Warfarin Dose Requirements in a South-east Asian Population View
NCT02065388 Pharmacogenetic Dosing of Warfarin View
NCT01492777 Pharmacogenetics of Acenocoumarol View
NCT00830570 The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings View
NCT00247702 The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR View
NCT00162435 Genetic Determinants of Warfarin Anticoagulation Effect View
NCT00377143 PRospective Evaluation Comparing Initiation of Warfarin StrategiEs PRECISE Pharmacogenetic-guided Versus Usual Care View
NCT00654823 Pharmacogenetic Study of Warfarin Dose-Response a Prospective Trial View